SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25
                                                  Commission File Number 0-18170

                           NOTIFICATION OF LATE FILING

(Check One): [X] Form 10-K and Form 10-KSB [ ] Form 11-K [ ] Form 20-F
             [ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR

For Period Ended:                                   December 31, 2002
[ ] Transition Report on Form 10-K          [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F          [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For Transition Period Ended:

  Read attached instruction sheet before preparing form. Please print or type.

         Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.

         If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION
                             BioLife Solutions, Inc.
- --------------------------------------------------------------------------------
Full name of registrant

Former name if applicable
                         Science 3, Suite 144, SUNY Park
- --------------------------------------------------------------------------------
Address of principal executive office (Street and number)

                              Binghamton, NY 13902
- --------------------------------------------------------------------------------
City, State and Zip Code



PART II - RULES 12B-25(b) AND (c)

    If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)

         (a) The reasons described in reasonable detail in Part III of this form
         could not be eliminated without unreasonable effort or expense;

         (b) The subject annual report, semi-annual report, transition report on
         Form 10-K, Form 20-F, 11-K or Form - N-SAR, or portion thereof, will
[X]      be filed on or before the fifteenth calendar day following the
         prescribed due date; or the subject quarterly report or transition
         report on Form 10-Q, or portion thereof will be filed on or before the
         fifth calendar day following the prescribed due date; and

         (c) The account's statement or other exhibit required by Rule 12b-25(c)
         has been attached if applicable.

PART III - NARRATIVE

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)

         The registrant's annual report on Form 10-KSB is being filed late
     because there were delays in completing the financial statements for the
     year ended December 31, 2002.





PART IV - OTHER INFORMATION

         (1) Name and telephone number of person to contact in regard to this
         notification

    John G. Baust               (607)           777-4415
- --------------------------------------------------------------------------------
       (Name)                (Area code)    (Telephone number)

         (2) Have all other periodic reports required under Section 13 or 15(d)
     of the Securities exchange Act of 1934 or Section 30 of the Investment
     Company Act of 1940 during the preceding 12 months or for such shorter
     period that the registrant was required to file such report(s) been filed?
     If the answer is no, identify report(s).

                                                                  [X] Yes [ ] No

         (3) Is it anticipated that any significant change in results of
     operations from the corresponding period for the last fiscal year will be
     reflected by the earnings statements to be included in the subject report
     or portion thereof?

                                                                  [ ] Yes [X] No

         If so, attach an explanation of the anticipated change, both
     narratively and quantitatively, and, if appropriate, state the reasons why
     a reasonable estimate of the results cannot be made.







                             BioLife Solutions, Inc.
- --------------------------------------------------------------------------------
                  (Name of registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date  March 31, 2003                 By   /s/ John G. Baust
                                          --------------------------------------
                                          John G. Baust, Chief Executive Officer

         Instruction. The form may be signed by an executive officer of the
     registrant or by any other duly authorized representative. The name and
     title of the person signing the form shall be typed or printed beneath the
     signature. If the statement is signed on behalf of the registrant by an
     authorized representative (other than an executive officer), evidence of
     the representative's authority to sign on behalf of the registrant shall be
     filed with the form.

                                    ATTENTION

Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).